Cecile Larrazet

Title: Cecile Larrazet: Innovator in MicroRNA Therapeutics

Introduction

Cecile Larrazet is a prominent inventor based in Montigny-le-Bretonneux, France. She has made significant contributions to the field of biotechnology, particularly in the area of microRNA therapeutics. Her innovative work focuses on addressing bowel inflammation, a condition that can severely impact patient health.

Latest Patents

Cecile Larrazet holds a patent for the use of the miR-27a-5p microRNA in treating induced bowel inflammation. This groundbreaking invention identifies an miRNA capable of greatly modulating the inflammatory response. The proposed application involves incorporating this microRNA into a pharmaceutical composition to prevent or reduce the harmful effects of infections on the bowels of affected patients. The miR-27a-5p microRNA can be linked to a matrix, incorporated into particles, or conveyed by a vector for therapeutic administration.

Career Highlights

Throughout her career, Cecile has worked with esteemed institutions, including Université Paris-Saclay and Assistance Publique—Hôpitaux de Paris. Her research has contributed to advancements in understanding and treating inflammatory conditions, showcasing her dedication to improving patient outcomes.

Collaborations

Cecile has collaborated with notable colleagues, including Imad Kansau and Hussein Kobeissy. These partnerships have further enriched her research and development efforts in the field of microRNA therapeutics.

Conclusion

Cecile Larrazet's innovative work in microRNA therapeutics represents a significant advancement in the treatment of bowel inflammation. Her contributions to biotechnology continue to inspire and pave the way for future research in this critical area of health.